Searched for
CHINA PHARMACEUTICAL FIRMS
Indian envoy pitches greater pharma exports, Chinese investment to deepen tiesIndia's ambassador to China, Vikram Doraiswami, stressed the importance of expanding access to Chinese markets for Indian pharmaceutical co...- Beyond China, beyond tariffs: India, Japan look to MSMEs to turn strategic ties into factory-floor partnershipsAs Japanese Prime Minister Sanae Takaichi visits India, industry sees the biggest opportunity not in tariff concessions but in supplier eco...
- India initiates anti-dumping probes against five products from China, other nationsThe five items are moulded soda-lime glass vials; electric tractors in 6x4 and 4x2 axle configuration in any form; cyanuric chloride; polye...
- India Inc wary of fresh trade headwinds as US weighs additional 12.5% tariffIndia faces a potential 12.5% US tariff on imports following a Section 301 investigation into forced labor import prohibitions. Industry le...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Bangladesh urges China to reduce trade gapBangladesh's Prime Minister Tarique Rahman urged China to reduce the trade gap and diversify exports during his Beijing visit. He sought su...
- India’s development ladder after AI: What comes next?India’s future prosperity may increasingly depend on empowering its smaller economic units to become more productive using AI.
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India’s trade strategy: Moving beyond FTAsCurrently, India’s FTA utilisation rate hovers around 25% compared to 70-80% in developed economies.
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- 12 years of PM Modi: Bold reforms, decisive decisions and political turning pointsAfter 12 years at the helm, Prime Minister Narendra Modi reflects on a transformative journey filled with key reforms that have altered Ind...
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- Alibaba, BYD, Baidu are helping China military - Pentagon makes shocking claimsUS-China relations: Pentagon's update on Monday comes months after it briefly released -- then withdrew -- an earlier version of the list w...
- US plans additional 12.5% tariff; India says talks on Section 301 probes ongoingThe US Trade Representative has proposed an additional 12.5% duty on 54 countries, including India, over alleged failure to restrict import...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- India should now focus on FTA implementation, utilisation by exporters: ExpertsFor India to leverage its Free Trade Agreements effectively, a paradigm shift in strategy is imperative. Experts caution that the disparity...
- India needs to raise R&D spending to 2 pc of GDP by 2035 to boost manufacturing: ReportIndia's manufacturing growth is hampered by low R&D spending, currently at 0.6% of GDP, a report highlights. To boost its manufacturing sha...
- Want to jump into the 'China is back' rally? Tread carefullyInvestors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...
- India’s 'China-plus-one' push needs tax ease and fast-track FTAs with developed nations: Arvind VirmaniIndia must reform its tax system and streamline clearances to attract global investments moving away from China. Economist Arvind Virmani e...
- Trump-Xi meeting crucial for global economic stability: Shaun ReinA high-stakes meeting between US President Trump and Chinese President Xi Jinping is closely watched for signs of stability amid escalating...
Load More
